Bone Mineral Loss and Fracture in Sarcoidosis: A Systematic Review and Meta-Analysis
Authors:
- Wai Chung YongWYWai Chung Yong
- Sikarin UpalaSUSikarin Upala
- Anawin SanguankeoASAnawin Sanguankeo
Open Access
- 30 June 2019
- journal article
- review article
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 34 (2) , 130-140
Abstract
Objectives: This meta-analysis aims to investigate the possibility of bone mineral loss and fracture in sarcoidosis. Materials and methods: A comprehensive search of the MEDLINE and Embase databases was performed from inception through August 2017. The inclusion criterion was observational studies evaluating the association between sarcoidosis and bone mineral density (BMD) or fracture. The pooled odds ratio (OR) of fracture, standardized mean difference (SMD) of volumetric BMD and areal BMD, and their 95% confidence interval (CI) were calculated using a random-effects meta-analysis to compare risk between sarcoidosis and controls. The between-study heterogeneity of effect-size was quantified using the Q statistic and I2. Results: Data were extracted from 10 studies involving a total of 6,448 sarcoidosis patients and 77,857 controls. The pooled result demonstrated no significant increased risk of fracture in sarcoidosis patients compared with controls (OR=1.68; 95% CI: 0.85-3.31, p value=0.14, I2=72%). There were no differences between the patients and controls in areal BMD (SMD= 0.21 g/cm2; 95% CI: -0.12-0.54, p value= 0.22, I2=0%) or volumetric BMD (SMD= 0.04 mg/cm3; 95% CI: -0.51-0.58, p value=0.89, I2=83%). Conclusion: Our study has not shown an increased risk of fracture or bone mineral loss in sarcoidosis. However, based on the currently available studies with heterogeneity in between, the conclusion for the osteoporosis screening and fracture risk assessment of patients with sarcoidosis cannot be drawn until more studies are available.Keywords
This publication has 23 references indexed in Scilit:
- Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosisOsteoporosis International, 2017
- Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976–2013Osteoporosis International, 2017
- Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohortOsteoporosis International, 2015
- Bone density is normal and does not change over 2 years in sarcoidosisOsteoporosis International, 2014
- Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United KingdomOsteoporosis International, 2013
- Bone Loss in Rheumatoid Arthritis: Systemic, Periarticular, and FocalCurrent Rheumatology Reports, 2012
- Bone Health Issues in SarcoidosisCurrent Rheumatology Reports, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Osteoimmunology — The hidden immune regulation of boneAutoimmunity Reviews, 2009
- Clinical assessment of the long‐term risk of fracture in patients with rheumatoid arthritisArthritis & Rheumatism, 2006